MG
VBIO

Marex Group’s Valion Bio VBIO Stock Holding History

Marex Group’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2K Sell
2,171
-200
-8% -$4.35K ﹤0.01% 1097
2026
Q1 		$52.5K Buy
2,371
+733
+45% +$18.8K ﹤0.01% 968
2025
Q4 		$59.4K Buy
1,638
+102
+7% +$5.82K ﹤0.01% 928
2025
Q3 		$111K Sell
1,536
-35
-2% -$3.02K ﹤0.01% 770
2025
Q2 		$163K Buy
+1,571
New +$169K ﹤0.01% 540

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Marex Group's VBIO Position: Q2 2026 in Review

Marex Group reduced its Valion Bio (VBIO) stake by 8.4% in Q2 2026, selling an estimated $4.35K and leaving 2,171 shares worth $28.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1097.

Marex Group first reported a position in VBIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $163K in Q2 2025. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • Marex Group held 2,171 shares of Valion Bio worth $28.2K as of Q2 2026.
  • Marex Group sold 200 Valion Bio shares in Q2 2026, an estimated $4.35K.
  • Valion Bio made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #1097 holding.
  • Marex Group first reported a position in Valion Bio in Q2 2025 and has held it in 5 quarters since.
  • Marex Group's Valion Bio position peaked at $163K in Q2 2025.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.